{"id":"https://openalex.org/W2010182307","doi":"https://doi.org/10.1159/000247540","title":"Topical Immunotherapy for Alopecia areata: Re-Evaluation of 139 Cases after an Additional Follow-Up Period of 19 Months","display_name":"Topical Immunotherapy for Alopecia areata: Re-Evaluation of 139 Cases after an Additional Follow-Up Period of 19 Months","publication_year":2009,"publication_date":"2009-10-08","ids":{"openalex":"https://openalex.org/W2010182307","doi":"https://doi.org/10.1159/000247540","mag":"2010182307","pmid":"https://pubmed.ncbi.nlm.nih.gov/1392112"},"language":"en","primary_location":{"id":"doi:10.1159/000247540","doi":"https://doi.org/10.1159/000247540","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000247540","pdf_url":null,"source":{"id":"https://openalex.org/S135397728","display_name":"Dermatology","issn_l":"1018-8665","issn":["1018-8665","1421-9832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011021880","display_name":"Pieter H.M. van der Steen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"P.H.M. van der Steen","raw_affiliation_strings":["Department of Dermatology, University of Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I145872427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111676667","display_name":"J.B.M. Boezeman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"J.B.M. Boezeman","raw_affiliation_strings":["Department of Dermatology, University of Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I145872427"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044278117","display_name":"Rudolph Happle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145872427","display_name":"Radboud University Nijmegen","ror":"https://ror.org/016xsfp80","country_code":"NL","type":"education","lineage":["https://openalex.org/I145872427"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"R. Happle","raw_affiliation_strings":["Department of Dermatology, University of Nijmegen, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University of Nijmegen, The Netherlands","institution_ids":["https://openalex.org/I145872427"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I145872427"],"apc_list":null,"apc_paid":null,"fwci":1.5905,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.82074326,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":96},"biblio":{"volume":"184","issue":"3","first_page":"198","last_page":"201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11167","display_name":"Hair Growth and Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11144","display_name":"melanin and skin pigmentation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alopecia-areata","display_name":"alopecia areata","score":0.9990000128746033},{"id":"https://openalex.org/keywords/contact-immunotherapy","display_name":"topical immunotherapy","score":0.9980000257492065},{"id":"https://openalex.org/keywords/diphenylcyclopropenone","display_name":"diphenylcyclopropenone","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hair-regrowth","display_name":"hair regrowth","score":0.9860000014305115},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.8159999847412109},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.6940000057220459},{"id":"https://openalex.org/keywords/drug-tolerance","display_name":"drug tolerance","score":0.6140000224113464},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8849999904632568},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.625}],"concepts":[{"id":"https://openalex.org/C2777524370","wikidata":"https://www.wikidata.org/wiki/Q5075435","display_name":"Alopecia areata","level":2,"score":0.9721198081970215},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7729144096374512},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7347564101219177},{"id":"https://openalex.org/C2781291010","wikidata":"https://www.wikidata.org/wiki/Q178580","display_name":"Period (music)","level":2,"score":0.490896999835968},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.46913382411003113},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12585267424583435},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.06917953491210938},{"id":"https://openalex.org/C24890656","wikidata":"https://www.wikidata.org/wiki/Q82811","display_name":"Acoustics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000287","descriptor_name":"Administration, Topical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000506","descriptor_name":"Alopecia Areata","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D003503","descriptor_name":"Cyclobutanes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003521","descriptor_name":"Cyclopropanes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000247540","doi":"https://doi.org/10.1159/000247540","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000247540","pdf_url":null,"source":{"id":"https://openalex.org/S135397728","display_name":"Dermatology","issn_l":"1018-8665","issn":["1018-8665","1421-9832"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology","raw_type":"journal-article"},{"id":"pmid:1392112","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1392112","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dermatology (Basel, Switzerland)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2134831974","https://openalex.org/W1563526529","https://openalex.org/W2396903968","https://openalex.org/W1563097646","https://openalex.org/W2225417185","https://openalex.org/W2157693114","https://openalex.org/W2404453045","https://openalex.org/W2077859218","https://openalex.org/W2413255571","https://openalex.org/W4312609383"],"abstract_inverted_index":{"Within":[0],"a":[1,21,57],"group":[2],"of":[3,23,28,60,68,79,82,104,107,150,154,159],"139":[4],"patients":[5,33,48,70,85,109,115,135,146],"previously":[6],"studied":[7],"during":[8],"treatment":[9,55],"for":[10,56],"alopecia":[11,155],"areata":[12,156],"with":[13,35,49,90,124],"diphenylcyclopropenone":[14],"(DCP),":[15],"hair":[16],"growth":[17],"was":[18],"re-evaluated":[19],"after":[20,95],"period":[22,59],"19":[24],"months":[25,62],"following":[26],"completion":[27],"our":[29],"previous":[30],"study.":[31],"Fifty-four":[32],"treated":[34,89],"DCP":[36,54,74,125],"had":[37,41,52,64,86,110,116,128],"total":[38,50,131],"and":[39,63,113,126,137,152],"6":[40],"partial":[42,117,139],"but":[43,118,140],"cosmetically":[44,119,141],"acceptable":[45,120],"regrowth.":[46,121],"Twenty-five":[47],"regrowth":[51,132,143],"stopped":[53],"mean":[58],"15":[61],"not":[65],"relapsed.":[66],"Nineteen":[67],"28":[69],"who":[71],"still":[72],"applied":[73],"were":[75,157],"in":[76,130,133,138,144],"the":[77,102],"process":[78],"stepwise":[80],"discontinuation":[81],"treatment.":[83],"Fifteen":[84],"subsequently":[87],"been":[88],"squaric":[91],"acid":[92],"dibutylester":[93],"(SADBE)":[94],"having":[96],"acquired":[97],"'tolerance'":[98],"to":[99],"DCP;":[100],"at":[101],"time":[103],"re-evaluation":[105],"3":[106],"these":[108],"complete":[111],"regrowth,":[112],"4":[114],"Topical":[122],"immunotherapy":[123],"SADBE":[127],"resulted":[129],"57/139":[134],"(41.0%)":[136],"satisfactory":[142],"10/139":[145],"(7.2%).":[147],"The":[148],"type":[149],"involvement":[151],"duration":[153],"factors":[158],"prognostic":[160],"significance.":[161]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}